TrialClinical rheumatology2016

A phase II investigator-initiated pilot study with low-dose cyclosporine A for the treatment of articular involvement in primary Sjögren's syndrome.

Claudia Kedor et al.PubMed ↗Publisher ↗

No numbers read from the abstract.